PRIMARY STUDY

Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer through Myeloid Cell De-activation Upstream of IL-22 Production

Key Findings:  Resulting data revealed that THC (via activation of CB2) is a potent suppressor of aberrant immune responses by provoking coordination between APCs and T regulatory cells and as such attenuates colitis-associated colon cancer and colitis induced by anti-CD40.